US Broker Ratings

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech Gem with 42% Upside Potential

Soleno Therapeutics, Inc. (NASDAQ: SLNO) presents an intriguing opportunity for investors keen on the biotechnology sector, particularly those focused on companies developing treatments for rare diseases. With a market capitalization..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Pioneer with 101% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biotechnology sector, continues to capture investor attention, not only due to its promising pipeline of radiopharmaceuticals but also because of..

Qiagen N.V. (QGEN) Stock Analysis: Navigating Potential 8.76% Upside in Diagnostics & Research

For individual investors keeping an eye on the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity within the diagnostics and research industry. Based in Venlo, Netherlands, Qiagen has..

Neurocrine Biosciences (NBIX) Stock Analysis: A 34% Upside Potential in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has captured the attention of investors with its robust performance in the healthcare sector, particularly in the field of neurological, neuroendocrine, and neuropsychiatric disorders. This..

HealthEquity, Inc. (HQY) Stock Analysis: A 31% Upside Potential for Investors

HealthEquity, Inc. (HQY), a prominent player in the Health Information Services industry, is making waves with its robust technology-enabled service platforms targeted at consumers and employers across the United States...

Akero Therapeutics, Inc. (AKRO): Analyst Consensus Suggests 51% Upside Potential

Akero Therapeutics, Inc. (NASDAQ: AKRO) is capturing investor attention in the healthcare sector, with a market capitalization of $4.02 billion and a strong focus on biotechnology. The company is at..

Bruker Corporation (BRKR): Investor Outlook on a Stock with 53.56% Potential Upside

Bruker Corporation (NASDAQ: BRKR) stands as a noteworthy player within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $4.62 billion, this Massachusetts-based company is..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 73% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently captivating the attention of investors with its robust portfolio in the healthcare sector, particularly in the drug manufacturing industry focusing on specialty and..

Alkermes plc (ALKS) Stock Analysis: Exploring a 55% Potential Upside with Robust Analyst Confidence

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industries, presents a compelling investment case for those eyeing the biopharmaceutical..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 24.98% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a heavyweight in the healthcare sector, is firmly positioned in the drug manufacturing industry with a specialization in both specialty and generic medications. With a..

ICON plc (ICLR) Stock Analysis: Unveiling a 38.1% Upside Opportunity in Healthcare Research

Investors seeking opportunities in the healthcare sector may want to take a closer look at ICON plc (NASDAQ: ICLR), a key player in the diagnostics and research industry. Headquartered in..

Glaukos Corporation (GKOS) Stock Analysis: A 44.67% Potential Upside Amidst Healthcare Innovations

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector with its innovative solutions for treating eye diseases. The company, headquartered in Aliso Viejo, California, specializes in ophthalmic pharmaceuticals..

Chemed Corp (CHE) Stock Analysis: A Lucrative 30% Upside Awaits Investors

Chemed Corp (NYSE: CHE) is a compelling investment opportunity in the healthcare sector, primarily due to its potential upside of 30.30%, as indicated by analyst ratings. With a market cap..

Bausch + Lomb (BLCO): Investor Outlook on a Healthcare Stalwart with 11% Potential Upside

Bausch + Lomb Corporation (BLCO) stands as a historic pillar in the healthcare sector, particularly within the medical instruments and supplies industry. With its roots tracing back to 1853, this..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook with a Potential 68.84% Upside

Investors looking for a compelling opportunity in the healthcare sector may find Axsome Therapeutics, Inc. (NASDAQ: AXSM) an intriguing prospect. As a biopharmaceutical company dedicated to advancing treatments for central..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating Growth Amidst Uncertain Valuations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player within the biotechnology sector, a space renowned for its innovation and volatility. With a current market capitalization of approximately $57.53..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with a 34.51% Upside Potential

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is currently spotlighted for its remarkable growth potential. With a market capitalization of $10.08 billion, this Waltham, Massachusetts-based company..

Insulet Corporation (PODD) Stock Analysis: Unpacking a 14.59% Potential Upside Amid Strong Analyst Ratings

Investors eyeing Insulet Corporation (NASDAQ: PODD) are witnessing a promising opportunity in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $21.62 billion, Insulet is..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Robust Pharmaceutical Play with 8.73% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a key player in the global pharmaceutical landscape, has captured investor attention with its diversified business model and consistent revenue growth. Based in Hyderabad,..

Cytokinetics, Inc. (CYTK) Stock Analysis: Unveiling a Potential 110% Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is drawing investor attention with its compelling potential upside of 110.93%. Based in South San Francisco, California, this late-stage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds